XML 16 R30.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings Per Share (Tables) | 6 Months Ended
--- | ---
Apr. 30, 2020
Earnings Per Share [Abstract] |
Reconciliation of Basic Weighted-Average Common Shares Outstanding to Diluted Weighted-Average Shares Outstanding | The table below reconciles basic weighted-average common shares outstanding to diluted weighted-average shares outstanding for the three and six months ended April 30, 2020 and April 30, 2019:
|  | Three Months Ended April 30, |  |  | Six Months Ended April 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Basic weighted-average common shares outstanding |  |  | 63,108,468 |  |  |  | 62,957,854 |  |  |  | 62,941,904 |  |  |  | 62,994,738 |
Dilutive stock options |  |  | — |  |  |  | 169,913 |  |  |  | — |  |  |  | — |
Dilutive restricted stock units |  |  | — |  |  |  | 219,847 |  |  |  | — |  |  |  | — |
Dilutive performance stock units |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Diluted weighted-average common shares outstanding |  |  | 63,108,468 |  |  |  | 63,347,614 |  |  |  | 62,941,904 |  |  |  | 62,994,738 |
Exclusions from Calculation of Weighted-Average Shares Outstanding Assuming Dilution Due to Anti-Dilutive Effect of Common Stock Equivalents | The table below represents exclusions from the calculation of weighted-average shares outstanding assuming dilution due to the anti-dilutive effect of the common stock equivalents for the three and six months ended April 30, 2020 and April 30, 2019:
|  | Three Months Ended April 30, |  |  | Six Months Ended April 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Anti-dilutive stock options |  |  | 651,600 |  |  |  | 172,951 |  |  |  | 779,600 |  |  |  | 988,551 |
Anti-dilutive restricted stock units |  |  | 2,724,840 |  |  |  | 497,925 |  |  |  | 2,905,823 |  |  |  | 1,750,723 |
Anti-dilutive performance stock units |  |  | — |  |  |  | 18,408 |  |  |  | — |  |  |  | 18,408 |
Anti-dilutive common stock equivalents |  |  | 3,376,440 |  |  |  | 689,284 |  |  |  | 3,685,423 |  |  |  | 2,757,682 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration